Insulin Aspart 50 biosimilar (Gan & Lee Pharma)
门冬胰岛素50生物类似药（甘李药业）
Report date: 2026/05/27 14:26:51
Base Information
Drug NameInsulin Aspart 50 biosimilar (Gan & Lee Pharma)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusN/A
Highest Status in ChinaN/A
Originator CompaniesGan & Lee Pharmaceuticals
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A